Peter Coleman’s Post

Experienced Clinical Scientist and marketer focused on genomic solutions in reproductive and genetic health and oncology.

8mo Edited

What are the considerations when choosing a new tertiary analysis software? Laboratories need solutions that are innovative, integrated, customisable and able to meet their needs. Join us on November 9th to learn how @Illumina Emedgene software can help you unlock genomic insights and confidently scale your tertiary analysis workflows for rare disease genomics and other germline research applications. Register today! #raredisease #germline #tertiaryanalysis #genomics #AI #automation

Unlock Genomic Insights for Rare & Hereditary Disease with Emedgene

sapac.illumina.com

To view or add a comment, sign in

More Relevant Posts

Peter Coleman

Experienced Clinical Scientist and marketer focused on genomic solutions in reproductive and genetic health and oncology.
2w Edited
Report this post
KSGD 2024 We are sponsoring and attending the Korean Society of Genetic Diagnostics scientific meeting in Seoul, South Korea. My colleague Thomas Klemm will be presenting tomorrow on “Genomic tools for genetic disease and cytogenetics”. Thankyou to our fantastic Illumina Korea team and Dow Biomedica. Enjoying the scientific presentations as well as the Korean food and weather. #KSGD #Illumina
Like Comment
To view or add a comment, sign in
Peter Coleman

Experienced Clinical Scientist and marketer focused on genomic solutions in reproductive and genetic health and oncology.
1mo
Report this post
Zero Childhood Cancer is a world-leading precision medicine program for children with cancer. Illumina is sponsoring and attending the annual scientific meeting in Sydney where we are hearing the latest research and updates from this impressive group of scientists, clinicians, genetic counsellors and others. Please feel free to drop by the booth and say hello to our team Joel Geoghegan, Katie Battese Ellis, Mynn Tan and Peter Coleman.
1 Comment
Like Comment
To view or add a comment, sign in
Peter Coleman

Experienced Clinical Scientist and marketer focused on genomic solutions in reproductive and genetic health and oncology.
3mo
Report this post
It has been wonderful catching up with colleagues and customers at #pathupdate2024 in Adelaide. I have seen some great presentations from episignatures, to WGS in cardiac conditions, to prenatal testing to comprehensive genomic profiling (CGP). Whether you are seeking answers or just want a chat - drop by the Illumina Booth (look for the pumpkin orange) and say hello. #illumina #genomics
4 Comments
Like Comment
To view or add a comment, sign in
Peter Coleman

Experienced Clinical Scientist and marketer focused on genomic solutions in reproductive and genetic health and oncology.
6mo
Report this post
A great collaboration between the Australasian Neuroscience Society and Illumina to support neurogenomic research, congratulations Alexandre Cristino. #neuroscience #genomics #illumina
Nicholas Tan (Boon)

Sr Reg. Segment Marketing Manager, AMEA
6mo

Congratulations Alexandre Cristino for receiving the 2023 ANS Illumina Neurogenomics award. Thanks for sharing your preliminary epigenomic results generated from the award at #ANS2023 As Dr Cristino mentions in his award presentation, the award is useful for generating data that can be useful for grant applications. Applications for the 2024 award is now open! Do come by to the #illumina booth to find out more. #genomics #multiomics #neuroscience #schizophrenia #epigenetics #methylation #infinium #array #grant #award
1 Comment
Like Comment
To view or add a comment, sign in
Peter Coleman

Experienced Clinical Scientist and marketer focused on genomic solutions in reproductive and genetic health and oncology.
7mo
Report this post
Come visit the Illumina booth at #ESMOASIA2023 Singapore and test your knowledge of biomarker and precision medicine treatments with our on booth game or speak to us about the benefits of comprehensive genomic profiling (CGP). #oncology #genomics #illumina
Like Comment
To view or add a comment, sign in
Peter Coleman

Experienced Clinical Scientist and marketer focused on genomic solutions in reproductive and genetic health and oncology.
8mo
Report this post
A great call to arms and summary of the current gaps and actions needed in Australia for equity of access to personalised medicine for rare cancers.
Rare Cancers Australia

4,985 followers
8mo

We must make the necessary changes to revolutionise our healthcare system now, so that it is fit for purpose and ready to deliver into the future. Why? Because all people diagnosed with cancer deserve the best possible person-centred care; care that truly meets their idiosyncratic needs. Thanks to the potential of personalised medicine, we now have the tools to make this a reality; it just remains up to us all to work collaboratively and deliver it. Read our four key recommendations for achieving timely and equitable access to precision oncology for all Australians diagnosed with cancer https://bit.ly/3M6K1xT #CanForum23 #rarefication #genomics #rarecancer #youarenotalone
Like Comment
To view or add a comment, sign in
Peter Coleman

Experienced Clinical Scientist and marketer focused on genomic solutions in reproductive and genetic health and oncology.
8mo
Report this post
What are the areas where ultrasound and genomics best complement each other? Yesterday I attended the pre conference workshop at ISUOG (South Korea) “Ultrasound meets genomics in obstetrics and prenatal care”sponsored by Illumina and the Society for Maternal-Fetal Medicine. Great speakers, engagement and discussion. Want to know more about reproductive health and the role genomics can play? Come see us at the Illumina booth (#8) #ISUOG2023 #Illumina #Genomics
1 Comment
Like Comment
To view or add a comment, sign in

775 followers

32 Posts

View Profile Follow

Peter Coleman’s Post

More Relevant Posts

Explore topics